Search

everythinglearnresearchcommunity

for

Search:↓

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Safflower extract helps protect hair follicle cells from damage caused by chemotherapy.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

Topical minoxidil may help regrow hair after permanent hair loss from chemotherapy.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Red ginseng may improve immunity, fatigue, memory, blood circulation, and menopausal symptoms, and is generally safe to consume.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.